Support Alert

Class 3 Medicines Recall: Latanoprost Timolol Eye drops

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 3 medicines recall for a batch of Latanoprost Timolol Eye drops. FDC Pharma are recalling a specified batch due to an out of specification result for an unknown impurity during stability testing. 

Further details of the alert, the affected batch, and action to take are available on the MHRA website.